4-(Benzyloxy)-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide

Catalog No. :
ACDKMJ995
CAS No. :
942195-85-9
Molecular Formula :
C25H25N3O4S
Molecular Weight :
463.56

IUPAC Name:4-(benzyloxy)-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide

4-(Benzyloxy)-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Benzyloxy)-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide
IUPAC Name4-(benzyloxy)-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide
MDL No.0
Molecular FormulaC25H25N3O4S
Molecular Weight463.56
SMILESO=C(C1=CC(OCC2=CC=CC=C2)=C3N=C(C)N(S(=O)(C4=CC=C(C)C=C4)=O)C3=C1)N(C)C
InChI KeyFFQSZTTXODRQOL-UHFFFAOYSA-N
Synonym4-(benzyloxy)-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide;N,N,2-trimethyl-1-[(4-methylphenyl)sulfonyl]-4-[(phenylmethyl)oxyl]-1H-benzimidazole-6-carboxamide;1H-Benzimidazole-6-carboxamide, N,N,2-trimethyl-1-[(4-methylphenyl)sulfonyl]-4-(phenylmethoxy)-;4-(Benzyloxy)-N,N,2-trimethyl-1-tosylbenzimidazole-6-carboxamide;Albendazole Impurity 52
CAS No.942195-85-9

Synthetic Route by SureRoute

1. ACDKMJ995 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDKMJ995 route product structure diagram
    ACDKMJ995942195-85-9
Inquiry

2. ACDKMJ995 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACHUHQ605 route compound structure diagram
    --
  6. Then
  7. ACDKMJ995 route product structure diagram
    ACDKMJ995942195-85-9
Inquiry

Comments (0)